Bank of America (BofA) has reiterated its ‘Neutral’ rating on PB Fintech with a target price of ₹1,850, citing strong core momentum in its business. The brokerage sees limited downside risk from PB Health’s foray into healthcare and insurance penetration, emphasizing that the company’s modest investment of under $100 million in the vertical mitigates the potential impact.
PB Fintech’s focus on solving insurance claims and improving penetration aligns with long-term growth trends, according to BofA. While short-term risks persist, the brokerage believes PB Health could offer optionality over a three-to-four-year horizon.
Despite macroeconomic challenges, PB Fintech continues to demonstrate resilience in its core insurance distribution business, with analysts optimistic about its ability to sustain growth amid evolving market dynamics.
Ahmedabad Plane Crash